Rezolute, Inc. (RZLT)
3.81
-0.09
(-2.31%)
USD |
NASDAQ |
Jun 10, 16:00
3.88
+0.07
(+1.84%)
After-Hours: 20:00
Rezolute EPS Diluted (TTM) : -0.809 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.809 |
| December 31, 2025 | -0.9237 |
| September 30, 2025 | -0.929 |
| June 30, 2025 | -0.974 |
| March 31, 2025 | -1.155 |
| December 31, 2024 | -1.221 |
| September 30, 2024 | -1.267 |
| June 30, 2024 | -1.329 |
| March 31, 2024 | -1.136 |
| December 31, 2023 | -1.106 |
| September 30, 2023 | -1.099 |
| June 30, 2023 | -1.011 |
| March 31, 2023 | -1.135 |
| December 31, 2022 | -1.481 |
| September 30, 2022 | -2.020 |
| June 30, 2022 | -2.746 |
| March 31, 2022 | -3.152 |
| December 31, 2021 | -2.943 |
| September 30, 2021 | -3.022 |
| June 30, 2021 | -2.719 |
| March 31, 2021 | -2.546 |
| December 31, 2020 | -2.963 |
| September 30, 2020 | -3.217 |
| June 30, 2020 | -3.539 |
| March 31, 2020 | -3.682 |
| Date | Value |
|---|---|
| December 31, 2019 | -20.64 |
| September 30, 2019 | -22.85 |
| June 30, 2019 | -24.62 |
| March 31, 2019 | -34.37 |
| December 31, 2018 | -21.15 |
| September 30, 2018 | -23.30 |
| June 30, 2018 | -27.09 |
| March 31, 2018 | -23.05 |
| December 31, 2017 | -24.84 |
| September 30, 2017 | -25.34 |
| June 30, 2017 | -24.34 |
| March 31, 2017 | -36.88 |
| December 31, 2016 | -38.00 |
| September 30, 2016 | -40.50 |
| June 30, 2016 | -42.00 |
| March 31, 2016 | -29.24 |
| December 31, 2015 | -28.74 |
| September 30, 2015 | -28.24 |
| June 30, 2015 | -27.24 |
| March 31, 2015 | -26.54 |
| December 31, 2014 | -247.54 |
| September 30, 2014 | -254.54 |
| June 30, 2014 | -254.54 |
| March 31, 2014 | -256.72 |
| December 31, 2013 | -64.72 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.740 |
| Inovio Pharmaceuticals, Inc. | -1.708 |
| SELLAS Life Sciences Group, Inc. | -0.2283 |
| Marker Therapeutics, Inc. | -0.6738 |
| ADMA Biologics, Inc. | 0.6779 |